Catalyst Wire Dossier Catalyst Wire Dossier

dolutegravir sodium

dolutegravir sodium
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for dolutegravir sodium, covering 2025-10-28 to 2025-10-28. Get the full timeline:

Most recent: FDA Approved: TRIUMEQ PD — Supplemental Application (ViiV Healthcare Company)

See pricing